A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622
Clinical trial NCT03306043 · COMPLETED
Trial details
- NCT number
- NCT03306043
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-13
- Primary completion
- 2019-12-30
- Enrollment
- 102
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.